Literature DB >> 7234877

Partial peripheral resistance to thyroid hormone.

M M Kaplan, S L Swartz, P R Larsen.   

Abstract

A 33 year old partially thyroidectomized woman was euthyroid when ingesting 500 microgram of L-triiodothyronine (T3) daily. Her condition was evaluated during therapy with daily T3 doses between 50 and 500 microgram. She was hypothyroid and had a markedly subnormal oxygen consumption rate when taking 50 to 100 microgram T3 daily, and oxygen consumption did not increase greatly above predicted normal values despite serum T3 concentrations up to 3,200 ng/dl. Her pulse rate, blood pressure, systolic time intervals and exercise tolerance changed minimally and remained within the normal range during the different dosage schedules. Urinary creatine and hydroxyproline, indices of muscle and skeletal protein catabolism, increased normally with higher T3 doses, but serum cholesterol, creatine phosphokinase, calcium and alkaline phosphatase did not change substantially. Basal and thyrotropin-releasing hormone (TRH) stimulated thyrotropin secretion were suppressed during all T3 doses. The prolactin response to TRH was normal at 50 microgram T3/day and was reduced by higher doses of T3. Absorption of T3, serum T3 protein binding and T3 metabolic clearance rates were all within normal limits. The findings in this patient are compared to clinical and biochemical findings in 17 previously described patients. The manifestations of peripheral thyroid hormone resistance are quite variable in the organ systems involved and in the degree of involvement. The molecular basis of the abnormality in our patient remains undefined.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7234877     DOI: 10.1016/0002-9343(81)90885-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Tight linkage of the human c-erbA beta gene with the syndrome of generalized thyroid hormone resistance is present in multiple kindreds.

Authors:  H G Fein; K D Burman; Y Y Djuh; S J Usala; A E Bale; B D Weintraub; R C Smallridge
Journal:  J Endocrinol Invest       Date:  1991-03       Impact factor: 4.256

Review 2.  Mutational Landscape of Resistance to Thyroid Hormone Beta (RTHβ).

Authors:  Paola Concolino; Alessandra Costella; Rosa Maria Paragliola
Journal:  Mol Diagn Ther       Date:  2019-06       Impact factor: 4.074

Review 3.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

4.  A case of hypersensitivity to thyroid hormones with normally functioning thyroid gland and increased nuclear triiodothyronine receptors.

Authors:  C Jaffiol; L Baldet; J Torresani; J Bismuth; C Papachristou
Journal:  J Endocrinol Invest       Date:  1990-11       Impact factor: 4.256

5.  A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.

Authors:  S J Usala; G E Tennyson; A E Bale; R W Lash; N Gesundheit; F E Wondisford; D Accili; P Hauser; B D Weintraub
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

6.  Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature.

Authors:  I M Spitz; M Sheinfeld; B Glasser; H J Hirsch
Journal:  Postgrad Med J       Date:  1984-05       Impact factor: 2.401

Review 7.  The syndromes of reduced sensitivity to thyroid hormone.

Authors:  Alexandra M Dumitrescu; Samuel Refetoff
Journal:  Biochim Biophys Acta       Date:  2012-08-16

8.  Refractory depression in a patient with peripheral resistance to thyroid hormone (RTH) and the effect of triiodothyronine treatment.

Authors:  Carlos E Fardella; Rocío A Artigas; Sergio Gloger; Marcela Jiménez; Cristian A Carvajal; Paola M Krall; Danilo Quiroz; Carmen Campino; Lorena M Mosso
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

9.  Familial generalized resistance to thyroid hormones: report of three kindreds and correlation of patterns of affected tissues with the binding of [125I] triiodothyronine to fibroblast nuclei.

Authors:  J A Magner; P Petrick; M M Menezes-Ferreira; M Stelling; B D Weintraub
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

10.  TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis.

Authors:  Johannes W Dietrich; Gabi Landgrafe; Elisavet H Fotiadou
Journal:  J Thyroid Res       Date:  2012-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.